Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety Study of NNZ-2566 in Healthy Subjects, Following Oral Administration
This study has been completed.
Study NCT01420042   Information provided by Neuren Pharmaceuticals Limited

First Received on August 17, 2011.   Last Updated on November 20, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Brain Injuries, Traumatic
Additional conditions recognized in this trial
Brain Injuries
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Craniocerebral Trauma
Nervous System Diseases
Trauma, Nervous System
Wounds and Injuries
Interventions listed in this trial
NNZ-2566
Placebo
Sponsors listed in this trial
Neuren Pharmaceuticals Limited


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services